Topical Wound Agents Market Size & Share, by Product Type (Creams, Gels, Powders, Lotions, Emulsions); Application {Acute Wound (Surgical & Traumatic Wound, Burns), Chronic Wound (Diabetic Foot Ulcer, Venous Leg Ulcer, Pressure Ulcer)}; End-user (Hospitals, Clinics); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4569
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Topical Wound Agents Landscape

top-features-companies
    • Smith & Nephew PLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Mölnlycke Health Care AB
    • Novartis Pharma AG
    • Pfizer Inc.
    • Johnson & Johnson Services, Inc.
    • Viatris Inc.
    • AstraZeneca PLC
    • Teva Pharmaceutical Industries Ltd.
    • Coloplast A/S
    • ConvaTec Limited

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Mölnlycke Health Care AB has announced the clinical results of its Mepilex Ag. This product has delivered effective results on a variety of wound types, including partial-thickness burns with low-to-medium exudate levels, thereby managing infection risks. Its soft silicone wound contact layer relieves wound and peri-wound pain caused by trauma and infection.

  • ConvaTec Limited has acquired Triad Life Sciences Inc. The Triad team, current portfolio, and product pipeline are projected to now exist as Convatec Advanced Tissue Technologies, under the Advanced Wound Care (AWC) brand.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4569
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing prevalence of chronic wounds, the increasing number of diabetic foot ulcers, the surge in burns cases, and the escalation in post-surgical wounds are some of the major factors estimated to drive the growth of the market.

The market is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2023-2033.

High cost of chronic wound treatment, the rising tendency in patients for urgent treatment, and competitive pricing of topical treatment products among manufacturers are some of the factors estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Smith & Nephew PLC, Mölnlycke Health Care AB, Novartis Pharma AG, Pfizer Inc., Johnson & Johnson Services, Inc., Viatris Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Coloplast A/S, ConvaTec Limited, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, application, end-user, distribution channel, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying